retatrutide parkinson's disease trial clinical Liraglutide once daily versus placebo in Parkinson's disease: a randomized, double-blind, placebo-controlled trial Time-to-event analysis mitigates the impact

Both GLP-1 agonists and heavy cannabis use are known to slow down the digestive process

NICE recommends treatment only within specialist weight management services, typically for a maximum of 2 years, and only if non-surgical weight management interventions have been unsuccessful

Muscle Loss Risk Increases (Major Concern) GLP-1 users already risk: low protein intake low calorie intake rapid weight loss lean tissue loss Add nightly alcohol and you get: impaired muscle protein synthesis lower testosterone (men) reduced growth hormone increased cortisol reduced recovery Result: More muscle loss Less fat loss Softer look Slower metabolism This is one of the biggest physiological downsides

Only English-language publications were included in our study, and papers published in peer-reviewed journals were included

Fibre Slows Digestion Fibre slows glucose absorption, helping reduce spikes and crashes that trigger hunger

Sleep deprivation increases ghrelin (the hunger hormone), reduces leptin (the satiety hormone), increases insulin resistance, and promotes cortisol-driven visceral fat storage